Lenva 4MG is a prescription medication used to treat various types of cancer, including:
- Unresectable hepatocellular carcinoma (HCC)
- Radioactive iodine-refractory differentiated thyroid cancer (DTC)
- Locally recurrent or metastatic thyroid cancer that is refractory to radioactive iodine
- Metastatic renal cell carcinoma (RCC)
Composition:
Lenva 4MG is a single-ingredient product containing Lenvatinib, a tyrosine kinase inhibitor.
Mechanism of Action:
Lenvatinib works by inhibiting the activity of multiple tyrosine kinases, which are enzymes that play a role in the growth and spread of cancer cells. Specifically, Lenvatinib inhibits the activity of vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR), which are important for the development of blood vessels and the growth of cancer cells.
Uses:
Lenva 4MG is used to treat various types of cancer, including:
- Unresectable HCC
- Radioactive iodine-refractory DTC
- Locally recurrent or metastatic thyroid cancer that is refractory to radioactive iodine
- Metastatic RCC
Dosage:
The recommended dosage of Lenva 4MG is:
- 4mg taken orally once daily, with or without food
- Continue treatment until disease progression or unacceptable toxicity
Side Effects:
Common side effects of Lenva 4MG include:
- Fatigue
- Diarrhea
- Hypertension
- Increased risk of bleeding
- Decreased white blood cell count
- Decreased platelet count
- Increased risk of heart failure
- Hypothyroidism
- Arthritis
- Rash
Recommendation:
Lenva 4MG is recommended for patients with advanced cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Lenva 4MG if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Lenva 4MG.
Please note that Lenva 4MG is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.